Schedule of Events

Why should you attend? Watch the video from Planning Committee member Dustin Boothe, MD, with Intermountain Healthcare as he shares why you won't want to miss this meeting!

View the 2026 Multidisciplinary Radiopharmaceutical Therapy Symposium schedule.

February 16, 2026

4:00 p.m. - 6:00 p.m.

Registration Open
South Registration Counter

February 17, 2026

7:00 a.m. - 4:15 p.m.	Registration Open South Registration Counter
7:00 a.m. - 8:00 a.m.	Continental Breakfast Springs Ballroom G
8:00 a.m. - 8:15 a.m.	Day One Welcome Springs Ballroom F
8:15 a.m. - 9:15 a.m.	Session I: Radiopharmaceutical Program Justification and Initial Start-up Springs Ballroom F Moderator: Ramji R. Rajendran, MD, PhD, Radiation Oncology Consultants Ltd Why Now is the Time to Build a Radiopharmaceutical Therapy Practice Dustin L. Boothe, MD, Intermountain Health Space Requirements for RPT Administration J. Travis Mendel, MD, Rio Grande Cancer Specialists The RAM License and SOP Development Ashley Cockerham, MSJ, Mercurie Consulting, LLC Clinic and Staffing Needs for RPT Delivery Brett E. Lewis, MD, PhD, Hackensack University Medical Center
9:15 a.m. - 10:00 a.m.	Keynote Springs Ballroom F Speaker: Johannes Czernin, MD, University of California
10:00 a.m. - 10:30 a.m.	Coffee Break and Poster Browsing in the Exhibit Hall Springs Ballroom G
10:30 a.m. - 11:30 a.m.	Session II: Authorized User Pathways and Physicist Training in Radiopharmaceutical Therapy Springs Ballroom F Moderator: Xinxin Zhang, PhD, Rutgers Cancer Institute of New Jersey/Robert Wood Johnson University Hospital The Path to Authorized User for Unsealed Byproduct Material Robert Tokarz, MS, DABR, Ackerman Cancer Center Physicist Training in RPT: The Beginnings of Structured Programs Robert Hobbs PhD, DABR, Johns Hopkins University QA and QC for Dose Calibrators, SPECT/CT and PET/CT Systems for Radiopharmaceutical Therapy John Sunderland, PhD, MBA, The University of Iowa
11:30 a.m. - 12:00 p.m.	Session III: Radiopharmaceutical Therapy Administration and the Role of the QMP Springs Ballroom F Moderator: Jacqueline E. Zoberi, PhD, Washington University of St. Louis Panel Session on RPT Administration and the Role of the QMP Jacqueline E. Zoberi, PhD, Washington University of St. Louis and Joseph G. Dise, MMP, AstraZeneca
12:00 p.m. - 12:30 p.m.	Session IV: Access to Therapy and Addressing Unmet Needs Springs Ballroom F Moderator: Jeffrey Y.C. Wong, MD, FASTRO, City of Hope Increasing Access to Radiopharmaceutical Therapy  Phillip Koo, MD, Prostate Cancer Foundation Addressing Unmet Needs in Radiopharmaceutical Therapy  Ravi Bhasker Patel, MD, PhD, University of Pittsburgh Medical Center
12:30 p.m. - 1:30 p.m.	Lunch and Poster Browsing in the Exhibit Hall Springs Ballroom G
1:30 p.m. - 3:00 p.m.	Plenary Session I Springs Ballroom G
3:00 p.m. - 4:15 p.m.	Session V: Building Beyond Initial Theranostics: Optimizing Operations, Coordination and Outcomes Springs Ballroom F Moderator: Arpit Michael Chhabra, MD, Bridge Oncology, New York Proton Center, Mt. Sinai Health System Revenue Cycle Management and Prior Authorization Challenges in Theranostics Programs Adam Brown, MBA, NMTCB, Integrated Theranostics Solutions Multidisciplinary Care Coordination Across Referring Providers Munir Ghesani, MD, United Theranostics Workflow Optimization: Software Utilization and Tracking Systems Erik Mittra, MD, PhD, Oregon Health and Science University Clinical Trials Development in Theranostics Programs: Practical Considerations Adam Brown, MBA, NMTCB, Integrated Theranostics Solutions
4:15 p.m. - 5:30 p.m.	Poster Session and Networking in the Exhibit Hall Springs Ballroom G

February 18, 2026

7:00 a.m. - 3:00 p.m.	Registration Open South Registration Counter
7:00 a.m. - 8:00 a.m.	Continental Breakfast Springs Ballroom G
8:00 a.m. - 8:15 a.m.	Day Two Welcome Springs Ballroom F
8:15 a.m. - 9:15 a.m.	Session VI: Experiences in Collaboration: A Tale of 3 Institutions Springs Ballroom F Moderator: Erin Grady, MD, Stanford University The Penn Medicine Experience Neil Kanth Taunik, MD, MS, Unversity of Pennsylvania Philipose G. Mulugeta, MD, University of Pennsylvania The Intermountain Health Experience Dustin L. Boothe, MD, Intermountain Health Eric Hu, MD, MBA, MPH, Intermountain Health Clinic The Stanford Experience Erin Grady, MD, Stanford University Mallika Marar, MD, MBA, Stanford University
9:15 a.m. - 10:00 a.m.	Session VII: Unique Challenges with Clinical Trials for Radiopharmaceutical Therapy Springs Ballroom F Moderator: Jeff Michalski, MD, MBA, FASTRO, Washington University of St. Louis RPT Clinical Trials — An Investigator and Drug Development Perspective Scott T. Tagawa, MD, New York-Presbyterian Hospital/Weill Cornell Medical Center RPT Trial Challenges in the National Clinical Trials Network Jonathan E. McConathy, MD, The University of Alabama at Birmingham Industry Perspective and Regulatory Challenges for RPT Clinical Trials Michael Morris, MD, Memorial Sloan Kettering Cancer Center
10:00 a.m. - 10:30 a.m.	Coffee Break and Poster Browsing in the Exhibit Hall Springs Ballroom G
10:30 a.m. - 11:30 a.m.	Session VIII: Clinical Challenges in Radiopharmaceutical Therapy Springs Ballroom F Moderator: Ana P. Kiess, MD, PhD, Johns Hopkins Infusion Troubleshooting and Radiation Safety Challenges with RPT Hyun Kim, MD, City of Hope Navigating Hematologic and Renal Dysfunction in RPT for Prostate Cancer Russell Szmulewitz, MD, University of Chicago When Should We Stop or Pause Treatment with RPT? Ana P. Kiess, MD, PhD, Johns Hopkins
11:30 a.m. - 12:30 p.m.	Session IX: Looking to the Future: Novel Targets Springs Ballroom F Moderator: Neil Kanth Taunk, MD, MS, University of Pennsylvania Noval Cancer-Specific Targets in Theranostics Freddy Escorcia, MD, PhD, RayzeBio Pan-cancer Targets in Theranostics Elcin Zan, MD, Cleveland Clinic The Potential and Challenges in Alpha Therapy Implementation Suzanne Lapi, PhD, The University of Alabama at Birmingham
12:30 p.m. - 1:30 p.m.	Lunch and Poster Browsing in the Exhibit Hall Springs Ballroom G
1:30 p.m. - 3:00 p.m.	Plenary Session II Springs Ballroom F
3:00 p.m. - 3:45 p.m.	Session X: Current Status and Challenges of Dosimetry Springs Ballroom F Moderator: Robert Hobbs, PhD, DABR, Johns Hopkins Status of RPT Dosimetry Methods and Results Yuni Dewaraja, MS, PhD, University of Michigan QA and Harmonization in RPT
3:45 p.m. - 4:15 p.m.	Coffee Break and Poster Browsing in the Exhibit Hall Springs Ballroom G
4:15 p.m. - 5:00 p.m.	Session XI: Radiobiological and Translational Aspects of RPTs Springs Ballroom F Moderator: Terence M. Williams, MD, PhD, City of Hope Radiobiological and Translational Aspects of RPT Zachary Scott Morris, MD, PhD, University of Wisconsin School of Medicine and Public Health Translational Aspects of RPT Anna Wu, PhD, City of Hope

American Society for Radiation Oncology
251 18th Street South, 8th Floor
Arlington, VA 22202
Telephone: 703-502-1550
www.astro.org

Attend

Experience

Learn

Exhibit Hall

Exhibitors

Schedule of Events

TERMS OF USE & PRIVACY POLICY

Connect With Us: